日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Kakehashi Inc Raises ¥14B in Series D Funding Round
KAKEHASHI Inc. is pleased to announce that it has signed an agreement…
Agilent debuts next-gen InfinityLab Pro iQ LC/MS systems
Agilent Technologies Inc. is pleased to announce the launch of the Agilent…
BONX WORK Integrates with Aiphone’s Vi-nurse System
BONX Inc. BONX WORK, based in Chuo-ku, Tokyo and led by CEO…
bitBiome Inc partners with leading CMO for Product Supply
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio Announces Strategic Collaboration with Stanford Medicine
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
SIOS Tech unveils Gluegent Gate Medical for cybersecurity
SIOS Technology just launched "Gluegent Gate Medical." This is a special version…
Lea Bio signs MOU with Vietnam’s top Healthcare network
Lea Bio Inc. is pleased to announce that it has signed a…
Digital Twins in Healthcare: How Japan Is Leading the Bio-Simulation Revolution
Japan has long blended advanced technology with strong cultural values. These values…
Latest Article
English